President Trump’s Condition: Regeneron CEO and Dr. Scott Gottlieb on POTUS Treatment

President Trump remains at Walter Reed National Military Medical Center, and treatments for his coronavirus diagnosis include an experimental antibody cocktail from Regeneron, dexamethasone, and Gilead’s remdesivir. CNBC’s Eamon Javers tracks the timeline of events since the President’s announcement, and CNBC’s Meg Tirrell explains the drugs in the President’s treatment plans. Former FDA Commissioner Dr. Scott Gottlieb deciphers the President’s likely condition from White House communications, and Regeneron CEO Dr. Leonard Schleifer discusses the status of the monoclonal antibody cocktail that was approved by the FDA for “compassionate use” in President Trump’s treatment. 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.